Terms: = Breast cancer AND TMPRSS2, PRSS10, 7113, ENSG00000184012, O15393 AND Treatment
12 results:
1. Impact of pharmacist consultation at clinical trial inclusion: an effective way to reduce drug-drug interactions with oral targeted therapy.
Leenhardt F; Alexandre M; Guiu S; Pouderoux S; Beaujouin M; Lossaint G; Philibert L; Evrard A; Jacot W
Cancer Chemother Pharmacol; 2021 Oct; 88(4):723-729. PubMed ID: 34286354
[TBL] [Abstract] [Full Text] [Related]
2. Novel Case of Isolated Peritoneal Carcinomatosis from Metastatic Prostate cancer Carrying a Pathogenic BRCA Mutation Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
King MC; Sardi A; Velez-Mejia C; Sittig M; Ledakis P
Urology; 2021 Sep; 155():210-213. PubMed ID: 34048828
[TBL] [Abstract] [Full Text] [Related]
3. COVIDENZA - A prospective, multicenter, randomized PHASE II clinical trial of enzalutamide treatment to decrease the morbidity in patients with Corona virus disease 2019 (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
Welén K; Överby AK; Ahlm C; Freyhult E; Robinsson D; Henningsson AJ; Stranne J; Bremell D; Angelin M; Lindquist E; Buckland R; Carlsson CT; Pauksens K; Bill-Axelsson A; Akre O; Ryden C; Wagenius M; Bjartell A; Nilsson AC; Styrke J; Repo J; Balkhed ÅÖ; Niward K; Gisslén M; Josefsson A
Trials; 2021 Mar; 22(1):209. PubMed ID: 33726804
[TBL] [Abstract] [Full Text] [Related]
4. Cross Talk between COVID-19 and breast cancer.
Parmar HS; Nayak A; Gavel PK; Jha HC; Bhagwat S; Sharma R
Curr Cancer Drug Targets; 2021; 21(7):575-600. PubMed ID: 33593260
[TBL] [Abstract] [Full Text] [Related]
5. The STAT3 Inhibitor Galiellalactone Reduces IL6-Mediated AR Activity in Benign and Malignant Prostate Models.
Handle F; Puhr M; Schaefer G; Lorito N; Hoefer J; Gruber M; Guggenberger F; Santer FR; Marques RB; van Weerden WM; Claessens F; Erb HHH; Culig Z
Mol Cancer Ther; 2018 Dec; 17(12):2722-2731. PubMed ID: 30254184
[TBL] [Abstract] [Full Text] [Related]
6. Accelerated partial breast irradiation with perioperative multicatheter interstitial brachytherapy-A feasibility study.
Pohanková D; Sirák I; Jandík P; Kašaova L; Grepl J; Motyčka P; Asqar A; Paluska P; Ninger V; Bydžovská I; Kopecky V; Petera J
Brachytherapy; 2018; 17(6):949-955. PubMed ID: 30227977
[TBL] [Abstract] [Full Text] [Related]
7. Driver Fusions and Their Implications in the Development and treatment of Human cancers.
Gao Q; Liang WW; Foltz SM; Mutharasu G; Jayasinghe RG; Cao S; Liao WW; Reynolds SM; Wyczalkowski MA; Yao L; Yu L; Sun SQ; ; ; Chen K; Lazar AJ; Fields RC; Wendl MC; Van Tine BA; Vij R; Chen F; Nykter M; Shmulevich I; Ding L
Cell Rep; 2018 Apr; 23(1):227-238.e3. PubMed ID: 29617662
[TBL] [Abstract] [Full Text] [Related]
8. Type II transmembrane serine protease gene variants associate with breast cancer.
Luostari K; Hartikainen JM; Tengström M; Palvimo JJ; Kataja V; Mannermaa A; Kosma VM
PLoS One; 2014; 9(7):e102519. PubMed ID: 25029565
[TBL] [Abstract] [Full Text] [Related]
9. ERG induces a mesenchymal-like state associated with chemoresistance in leukemia cells.
Mochmann LH; Neumann M; von der Heide EK; Nowak V; Kühl AA; Ortiz-Tanchez J; Bock J; Hofmann WK; Baldus CD
Oncotarget; 2014 Jan; 5(2):351-62. PubMed ID: 24504051
[TBL] [Abstract] [Full Text] [Related]
10. [Structural and functional analysis of tumor genomes and the development of test systems for early diagnosis, prognosis and cancer therapy optimization].
Zaletaev DV; Strel'nikov VV; Nemtsova MV; Babenko OV; Kuznetsova EB; Zemliakova VV; Kekeeva TV; Mikhaĭlenko DS; Tanas AS; Rudenko VV; Babaian AIu; Alekseeva EA; Simonova OA
Vestn Ross Akad Med Nauk; 2013; (9):7-14. PubMed ID: 24624866
[TBL] [Abstract] [Full Text] [Related]
11. Prevalence and risk factors for insomnia among breast cancer patients on aromatase inhibitors.
Desai K; Mao JJ; Su I; Demichele A; Li Q; Xie SX; Gehrman PR
Support Care Cancer; 2013 Jan; 21(1):43-51. PubMed ID: 22584732
[TBL] [Abstract] [Full Text] [Related]
12. Genome-wide functional screen identifies a compendium of genes affecting sensitivity to tamoxifen.
Mendes-Pereira AM; Sims D; Dexter T; Fenwick K; Assiotis I; Kozarewa I; Mitsopoulos C; Hakas J; Zvelebil M; Lord CJ; Ashworth A
Proc Natl Acad Sci U S A; 2012 Feb; 109(8):2730-5. PubMed ID: 21482774
[TBL] [Abstract] [Full Text] [Related]
